The newsletter is not displayed correctly? Please click here.

Newsletter 8/2010

6 May 2010

[gs]  

Clinical Diagnostics & bioMérieux –

New [MSC] Newsletter & Milestones

or: The Netherlands, revisited

If you do not wish to receive this newsletter anymore, just reply to this mail without any comment and you will be taken off the mailing list.

Dear reader,

right now eveybody seems to move into clinical diagnostics, so we took the opportunity to take a look at a company who has always been there:
bioMérieux S.A., France

In April alone bioMérieux announced two interesting deals to expand its own technology base: 

– a collaboration with Knome (US) in DNA Sequencing and  the 

– purchase of a spectral library from AnagnosTec (Germany) for mass spectrometry.

bioMérieux S.A.. (4/21/10). "Press Release: bioMérieux and Knome Sign Startegic Partnership". Marcy l’Etoile & Cambridge, MA.

bioMérieux S.A.. (4/12/10). "Press Release: bioMérieux Acquires from AnagnosTec Database and Expertise for Rapid Microbial Identification Using Mass Spectrometry". Marcy l’Etoile.

In addition: this [gs] newsletter will elaborate on two other things:

1)     Mass-Spec-Capital.com

Our new web portal today reached a defining first milestone covering more than 1,000 organisations related to mass spectrometry as of today!

In addition, Mass-Spec-Capital will launch a free, monthly [MSC] Newsletter this month. You can subscribe at www.mass-spec-capital.com

2)      The Netherlands and [gs]

[gs] now offers access to 350+ life sciences organisations from Holland directly via provinces and towns.

With this [gs] offers regional data for all German-speaking countries, the UK, North America and The Netherlands! Other European countries will follow soon.

a) Clinical Diagnostics and bioMérieux

In these times everybody seems to move into clinical diagnostics. The reason (I suspect): this is the right (hype) time for personalised medicine! And diagnostics (as well as vaccines) are great markets to enter because you don't have to restrict your marketing to persons that are "really ill", in fact, with the right marketing you can sell your vaccine and test to anybody – sick or healthy – all around the world!

While in principle preventing disease should be less costly than treating disease, in "reality" – and this will be true at least for the next years – the move into broad diagnostic screening campaigns is likely to let healthcare costs explode in the rich countries. For the poor countries the old wisdom holds true: buy and finance education instead of medicines.

There are several reasons for this, like follow-up costs, legal issues, social behavior, players in relevant markets etc., that have to be discussed in other contexts in more depth.

Anyway, bioMérieux, a French firm, has been a key player in clinical diagnostics (the traditional way, i.e. testing only people with a suspected disease, not population wide screening!) for many decades.

While other move into clinical diagnostics, bioMérieux has been there for a long time and reaches out to relevant technologies to round up its own product and technology portfolio and has done some interesting deals in the last few months.

The following transactions are just some intriguing examples, there were even more deals!

Selected transactions by bioMérieux S.A.

bioMérieux S.A.. (4/21/10). "Press Release: bioMérieux and Knome Sign Startegic Partnership". Marcy l’Etoile & Cambridge, MA. 2010-04-21

bioMérieux S.A.. (4/12/10). "Press Release: bioMérieux Acquires from AnagnosTec Database and Expertise for Rapid Microbial Identification Using Mass Spectrometry". Marcy l’Etoile. 2010-04-12

bioMérieux S.A.. (1/14/10). "Press Release: bioMérieux Acquires Chinese Rapid Test Manufacturer Meikang Biotech". Marcy l’Etoile. 2010-01-14

bioMérieux S.A.. (1/7/10). "Press Release: Philips and bioMérieux Announce Partnership to Develop and Market Next-generation Handheld Diagnostic Solutions for Point-of-Care". Amsterdam & Marcy l’Etoile. 2010-01-07

Life Technologies Corporation. (6/2/09). "Press Release: French Researchers Accelerate Biomarker Research with QTRAP® 5500 Mass Spectrometry Systems. Scientists at bioMérieux and the University of Lyon Speed Biomarker Discovery and Validation for Potenti 2009-06-02

bioMérieux S.A.. (12/8/08). "Press Release: bioMérieux Acquires Culture Media Specialist PML Microbiologicals. bioMérieux’s Recurring Sales Will Be Boosted by Expanded Reagent Range". Marcy-l’Etoile. 2008-12-08

bioMérieux S.A.. (9/11/08). "Press Release: bioMérieux Gains Critical Oncology and Theranostics Capabilities with the Acquisition of Molecular Diagnostics Company AviaraDx". Marcy-l’Etoile. 2008-09-11

bioMérieux S.A.. (3/17/08). "Press Release: bioMérieux and Hitachi High-Technologies Corporation Enter into Long-term Strategic Partnership Focus on Microbiology and Molecular Diagnostics". 2008-03-17 

bioMérieux S.A.. (1/15/08). "Press Release: Quidel and bioMérieux Announce a Global Strategic Alliance in Rapid Diagnostics". 2008-01-15

bioMérieux S.A.. (1/10/08). "Press Release: Sysmex and bioMérieux Form a Commercial Joint Venture for the Japanese In Vitro Diagnostics". Kobe. 2008-01-10

ExonHit Therapeutics S.A.. (1/9/08). "Press Release: ExonHit and bioMérieux Amend Their Strategic Partnership". Paris. 2008-01-09

bioMérieux S.A.. (10/8/07). "Press Release: bioMérieux and Compliance Software Solutions Corp. Partner to Enhance Data Management for the Pharmaceutical Industry". Marcy-l’Etoile. 2007-10-08

bioMérieux S.A.. (9/17/07). "Press Release: bioMérieux and Ipsen Sign Theragnostic Agreement to Develop Companion Test for New Breast Cancer Treatment". Marcy-l’Etoile & Paris. 2007-09-17

Sloning BioTechnology. (8/1/07). "Press Release: Sloning BioTechnology Starting Feasibility Study for bioMérieux". Puchheim. 2007-08-01

Sysmex Corporation. (7/2/07). "Press Release: Sysmex and bioMérieux Form a global Partnership for Urinary Screening in Microbiology". Kobe & Marcy l'Etoile. 2007-07-02

bioMérieux S.A.. (6/4/07). "Press Release: Eiken Chemical Co., Ltd. and bioMérieux Enter into Business Collaboration for Pre-poured Media". Bunkyo-ku, Tokyo & Marcy l’Etoile. 2007-06-04

bioMérieux S.A.. (5/22/07). "Press Release: AdvanDx and bioMérieux Partner to Provide Rapid Results for Bloodstream Infections". Woburn, MA & Marcey l'Etoile. 2007-05-22

bioMérieux S.A.. (5/9/07). "Press Release: bioMérieux and NuGEN Technologies Announce Cross-license and Supply Agreement". Marcy-l’Etoile & San Carlos, CA. 2007-05-09

bioMérieux S.A.. (4/30/07). "Press Release: LabTech Systems Ltd Secures Strategic Private Placement with bioMérieux". Adelaide & Marcy L'Eltoile. 2007-04-30

bioMérieux S.A.. (4/18/07). "Press Release: bioMérieux and LabTech Systems Sign exclusive Worldwide License Agreement for Innovative Robotic Microbiological Instrumentation". Marcy-l’Etoile. 2007-04-18

bioMérieux S.A.. (4/2/07). "Press Release: bioMérieux Strengthens Its Position in Bacteriology with the Acquisition of the Spanish Firm Biomedics". Marcy-l’Etoile. 2007-04-02

Cepheid. (1/17/07). "Press Release: Cepheid and bioMérieux Enter into Strategic Agreements to Develop and Market Sepsis and MRSA Products". Marcy-l’Etoile & Sunnyvale, CA. 2007-01-17

bioMérieux S.A.. (1/17/07). "Press Release: bioMérieux Licenses Technology from NorChip to Launch a HPV test for Cervical Cancer Risk Detection". 2007-01-17

bioMérieux, Inc.. (9/18/06). "Press Release: bioMerieux, Inc. Acquires Innovative Microbial Genotyping Technology. bioMerieux to Significantly Advance Infection Control and Process Assurance Capabilities". Durham, NC. 2006-09-18

[list continues... ]

A global search with »gene-sensor« provides comprehensive results with regard to the activities of bioMérieux:

Global Search › Result

Search term »biomerieux«

• 217 documents
• 22 organisations
• 76 products
• 23 persons
• 57 collaborations
• 16 financings
• 426 relations [organisation : index term]
• 209 relations [organisation : product]
• 303 relations [product : index term]
• 2 legal proceedings
• 9 abstracts

--------------------------------------------------

Please note: the links above are accessible online only for [gs] subscribers.

---------------------------------------------------

b) Mass-Spec-Capital.com
     Milestones & Launch of New, Free [MSC] Newsletter

After just two month our mass spec web portal at www.mass-spec-capital.com reached a significant milestone with the latest database update:

[iito] Business Intelligence is not going to share your personal data with any third party. Your e-mail address will only be used to deliver the newsletter.

---------------------------------------------------

c) The Netherlands, revisted

 
 
[iito] is constantly expanding its depth of regional coverage. Coverage in general is worldwide ever since we started back in 2002, with a clear focus on Europe and North America. 

 
As of today we are proud to announce that The Netherlands are the latest country that has been broken down to federal states or provinces within the [gs] database.

Now the country "The Netherlands" looks like this with gene-sensor.com *

Region › Details

Netherlands 

And you can go down one more level and look at any town in Holland (i.e. The Netherlands) with life sciences organisations listed in gene-sensor: more than 360 organisations as of today!

At the moment [gs] provides state/provincial level information for the following countries:

Germany

Austria

Switzerland

The Netherlands

United Kingdom

United States

Canada

Until year-end we intend to expand this coverage to most European countries.

-------------------------------------------------------------------------------

That is all for now. Please try our new, free mass spectrometry newsletter. You can subscribe at www.mass-spec-capital.com !

Thanks for reading, back in 14 days!

Marcus Lippold 

©2010 by [iito] Business Intelligence


NOTES & DISCLAIMER

Some links are available to subscribers only. As this newsletter is a free service, available to anybody without a contractual agreement, the writer disclaims any liabilities and explicitly advises you, not to use this information for your own business decisions. 

I hope you enjoy reading these lines as much as I have enjoyed writing them!

Thank you.

Marcus Lippold
Dipl.-Oek. (Economist)

[iito] Business Intelligence
Parkallee 24
28209 Bremen
Germany

Phone +49(0)-421-62659 196
Fax +49(0)-700-4-367-367-6
E-mail mlippold@iito.de
Web www.iito.de

This communication is confidential. If you are not the intended recipient, you should not copy or disclose the message to anyone, but should kindly notify the sender and delete the message.

A project of [iito] Business Intelligence© 2002-2010. Made in Germany.